Healthcare provider profile · identity verified

Raymond Todd Wiblin, MD

Internal Medicine · CORALVILLE, IA · NPI 1609858034

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	529	140
Lisinopril	Lisinopril	308	93
Amlodipine Besylate	Amlodipine Besylate	267	80
Gabapentin	Gabapentin	246	65
Metformin Hcl	Metformin Hcl	231	61
Losartan Potassium	Losartan Potassium	228	60
Omeprazole	Omeprazole	227	64
Metoprolol Succinate	Metoprolol Succinate	201	59
Levothyroxine Sodium	Levothyroxine Sodium	198	56
Tamsulosin Hcl	Tamsulosin Hcl	155	47
Pantoprazole Sodium	Pantoprazole Sodium	146	36
Ozempic	Semaglutide	143	18
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	139	21
Hydrochlorothiazide	Hydrochlorothiazide	127	38
Furosemide	Furosemide	124	40
Famotidine	Famotidine	112	30
Eliquis	Apixaban	111	26
Finasteride	Finasteride	111	30
Fluticasone Propionate	Fluticasone Propionate	111	26
Allopurinol	Allopurinol	108	28
Metoprolol Tartrate	Metoprolol Tartrate	108	31
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	102	19
Escitalopram Oxalate	Escitalopram Oxalate	91	26
Metformin Hcl Er	Metformin Hcl	90	27
Sertraline Hcl	Sertraline Hcl	89	18
Rosuvastatin Calcium	Rosuvastatin Calcium	88	27
Warfarin Sodium	Warfarin Sodium	86	20
Albuterol Sulfate Hfa	Albuterol Sulfate	84	34
Montelukast Sodium	Montelukast Sodium	83	24
Hydromorphone Hcl	Hydromorphone Hcl	79	suppressed
Simvastatin	Simvastatin	79	23
Tramadol Hcl	Tramadol Hcl	78	14
Jardiance	Empagliflozin	74	15
Lorazepam	Lorazepam	73	15
Clonazepam	Clonazepam	69	suppressed
Pregabalin	Pregabalin	69	12
Carvedilol	Carvedilol	68	17
Diazepam	Diazepam	67	suppressed
Pravastatin Sodium	Pravastatin Sodium	65	19
Zolpidem Tartrate	Zolpidem Tartrate	64	14
Potassium Chloride	Potassium Chloride	61	19
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	57	17
Nortriptyline Hcl	Nortriptyline Hcl	57	13
Sumatriptan Succinate	Sumatriptan Succinate	57	suppressed
Spironolactone	Spironolactone	56	17
Duloxetine Hcl	Duloxetine Hcl	55	22
Morphine Sulfate Er	Morphine Sulfate	55	suppressed
Ondansetron Odt	Ondansetron	54	21
Trazodone Hcl	Trazodone Hcl	54	23
Oxybutynin Chloride Er	Oxybutynin Chloride	53	19
Methadone Hcl	Methadone Hcl	51	suppressed
Oxycodone Hcl	Oxycodone Hcl	51	suppressed
Clopidogrel	Clopidogrel Bisulfate	49	12
Celecoxib	Celecoxib	48	11
Glipizide Er	Glipizide	47	14
Ventolin Hfa	Albuterol Sulfate	47	suppressed
Baclofen	Baclofen	43	11
Atenolol	Atenolol	39	suppressed
Propranolol Hcl Er	Propranolol Hcl	39	11
Nitroglycerin	Nitroglycerin	38	12
Tizanidine Hcl	Tizanidine Hcl	38	suppressed
Topiramate	Topiramate	38	suppressed
Alendronate Sodium	Alendronate Sodium	37	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	36	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	36	14
Chlorthalidone	Chlorthalidone	35	suppressed
Glimepiride	Glimepiride	35	11
Morphine Sulfate	Morphine Sulfate	34	suppressed
Alprazolam	Alprazolam	33	suppressed
Nabumetone	Nabumetone	33	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	32	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	31	11
Gemfibrozil	Gemfibrozil	30	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	30	suppressed
Mirtazapine	Mirtazapine	30	suppressed
Fenofibrate	Fenofibrate,micronized	29	suppressed
Spiriva Handihaler	Tiotropium Bromide	29	suppressed
Novolog Flexpen	Insulin Aspart	28	suppressed
Prednisone	Prednisone	27	13
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Valsartan	Valsartan	25	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	24	suppressed
Methocarbamol	Methocarbamol	24	suppressed
Naproxen	Naproxen	24	suppressed
Ezetimibe	Ezetimibe	23	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	23	suppressed
Azithromycin	Azithromycin	22	suppressed
Lansoprazole	Lansoprazole	22	suppressed
Levetiracetam	Levetiracetam	22	suppressed
Meloxicam	Meloxicam	22	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	22	suppressed
Acyclovir	Acyclovir	21	suppressed
Arnuity Ellipta	Fluticasone Furoate	21	suppressed
Mounjaro	Tirzepatide	21	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	21	suppressed
Bupropion Xl	Bupropion Hcl	20	suppressed
Irbesartan	Irbesartan	20	suppressed
Ondansetron Hcl	Ondansetron Hcl	20	suppressed
Sucralfate	Sucralfate	20	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	19	19
Clindamycin Phosphate	Clindamycin Phosphate	19	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	19	suppressed
Donepezil Hcl	Donepezil Hcl	18	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	18	12
Fentanyl	Fentanyl	18	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	18	suppressed
Creon	Lipase/Protease/Amylase	17	suppressed
Diclofenac Sodium	Diclofenac Sodium	17	suppressed
Tresiba Flextouch U-100	Insulin Degludec	17	suppressed
Verapamil Er	Verapamil Hcl	17	suppressed
Colesevelam Hcl	Colesevelam Hcl	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Hydrocortisone	Hydrocortisone	16	suppressed
Insulin Syringe	Syringe And Needle,insulin,1ml	16	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	15	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	15	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	suppressed
Enalapril Maleate	Enalapril Maleate	15	suppressed
Epinephrine	Epinephrine	15	suppressed
Incruse Ellipta	Umeclidinium Bromide	15	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	15	suppressed
Ketoconazole	Ketoconazole	15	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	15	suppressed
Testosterone Cypionate	Testosterone Cypionate	15	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	15	suppressed
Buspirone Hcl	Buspirone Hcl	14	suppressed
Citalopram Hbr	Citalopram Hydrobromide	14	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Amoxicillin	Amoxicillin	13	suppressed
Benazepril Hcl	Benazepril Hcl	13	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	13	suppressed
Colchicine	Colchicine	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Niacin Er	Niacin	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Prasugrel Hcl	Prasugrel Hcl	13	suppressed
Ranolazine Er	Ranolazine	13	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	12	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Hydrocodone Bitartrate Er	Hydrocodone Bitartrate	12	suppressed
Telmisartan	Telmisartan	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	11	suppressed
Carbamazepine Er	Carbamazepine	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Ibandronate Sodium	Ibandronate Sodium	11	suppressed
Penicillin V Potassium	Penicillin V Potassium	11	suppressed
Xarelto	Rivaroxaban	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error